![Garth Lees-Rolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garth Lees-Rolfe
Direttore/Membro del Consiglio presso
LUDWIG ENTERPRISES, INC.
Profilo
Mr. Garth Lees-Rolfe, CPA, is an Independent Director at Ludwig Enterprises, Inc. He is on the Board of Directors at Ludwig Enterprises, Inc. Mr. Lees-Rolfe was previously employed as a Chief Financial & Accounting Officer by Inhibikase Therapeutics, Inc. and a Vice President-Finance by F-star Therapeutics, Inc. He received his undergraduate degree from Queensland University of Technology.
Posizioni attive di Garth Lees-Rolfe
| Società | Posizione | Inizio |
|---|---|---|
| LUDWIG ENTERPRISES, INC. | Direttore/Membro del Consiglio | 23/06/2025 |
Precedenti posizioni note di Garth Lees-Rolfe
| Società | Posizione | Fine |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 11/04/2025 |
| F-STAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 |
Formazione di Garth Lees-Rolfe
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Enterprises, Inc.
 Ludwig Enterprises, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
